Optimal Programming of Implantable Cardiac-Defibrillators

Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death risk and improve survival in patients with a history of life-threatening arrhythmia or cardiac arrest (secondary prevention) and in high-risk patients without such a history (primary prevention).1–3 Patients with ICDs, however, may receive unnecessary shocks, which have been associated with proarrhythmia, anxiety, depression, poor quality of life, and possibly increased mortality.4–8 In contrast to drug therapy, in which a limited number of parameters (such as dose) are adjustable, hundreds of programmable parameters affect device therapy delivery. Moreover, selection of nonnominal parameter settings (ie, changing the out-of-the-box factory default settings) reduces morbidity and mortality compared with nominal settings in many clinical situations because of publication and regulatory delays.4,9,10 Thus, optimization of programming to prevent unnecessary shocks is paramount to minimize morbidity and mortality and is dependent on clinician proactivity. Delivery of ICD therapy for rhythms other than ventricular tachycardia (VT) or ventricular fibrillation (VF) is termed inappropriate therapy . It may result from inappropriate detection of supraventricular tachycardia (SVT) such as atrial fibrillation (AF) or sinus tachycardia or from oversensing of physiological (eg, T wave) or nonphysiological (eg, lead fracture noise) signals. Inappropriate shocks have been reported in 16% to 18% of ICD recipients and constitute 30% to 50% of all shocks.11–13 Although therapy delivered for a ventricular tachyarrhythmia is considered appropriate, a growing body of evidence has shown that programming antitachycardia pacing (ATP) or delaying shocks to permit nonsustained episodes to terminate significantly reduces the frequency of shock delivery. Koneru et al14 have used the term unnecessary shocks to refer to inappropriate shocks delivered for rhythms other than VT/VF and to include shocks delivered for VT that would have responded to ATP or terminated spontaneously if given time. Optimal programming minimizes unnecessary shocks. A …

[1]  K. Ellenbogen,et al.  Advances in Arrhythmia and Electrophysiology Minimizing Inappropriate or “Unnecessary” Implantable Cardioverter-Defibrillator Shocks Appropriate Programming , 2011 .

[2]  W. Grimm,et al.  Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients with Prophylactic Cardioverter‐Defibrillator Therapy , 2006, Pacing and clinical electrophysiology : PACE.

[3]  N. V. van Hemel,et al.  Far‐Field R‐Wave Reduction with a Novel Lead Design: Experimental and Human Results , 2005, Pacing and clinical electrophysiology : PACE.

[4]  M. Gold,et al.  Advanced Rhythm Discrimination for Implantable Cardioverter Defibrillators Using Electrogram Vector Timing and Correlation , 2002, Journal of cardiovascular electrophysiology.

[5]  A. Natale,et al.  Prospective Evaluation of New and Old Criteria to Discriminate Between Supraventricular and Ventricular Tachycardia in Implantable Defibrillators , 1998, Pacing and clinical electrophysiology : PACE.

[6]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[7]  P. S. Chen,et al.  Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. , 1994, Journal of the American College of Cardiology.

[8]  A. Willems,et al.  Clinical Results of Far‐Field R‐Wave Reduction with a Short Tip‐Ring Electrode , 2008, Pacing and clinical electrophysiology : PACE.

[9]  L. Fauchier,et al.  Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  A. Vinet,et al.  Underdetection of Ventricular Tachycardia Using a 40 ms Stability Criterion: Effect of Antiarrhythmic Therapy , 1997, Pacing and clinical electrophysiology : PACE.

[11]  P. Heidenreich,et al.  Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.

[12]  P. Friedman,et al.  Advanced ICD Troubleshooting: Part II , 2005 .

[13]  C. Schmitt,et al.  Do Current Dual Chamber Cardioverter Defibrillators Have Advantages Over Conventional Single Chamber Cardioverter Defibrillators in Reducing Inappropriate Therapies? A Randomized, Prospective Study , 2001, Journal of cardiovascular electrophysiology.

[14]  M. Sweeney,et al.  Antitachycardia Pacing for Ventricular Tachycardia Using Implantable Cardioverter Defibrillators: , 2004, Pacing and clinical electrophysiology : PACE.

[15]  Paul A. Belk,et al.  Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia? , 2007, Journal of the American College of Cardiology.

[16]  R. Schweikert,et al.  Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.

[17]  Stephen L Moore,et al.  Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.

[18]  B. Wilkoff,et al.  Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. , 2010, Heart rhythm.

[19]  R. Villareal,et al.  Effects of a rate smoothing algorithm for prevention of ventricular arrhythmias: results of the Ventricular Arrhythmia Suppression Trial (VAST). , 2006, Heart rhythm.

[20]  J. Brugada,et al.  Enhanced Detection Criteria in Implantable Defibrillators , 1998, Journal of cardiovascular electrophysiology.

[21]  Emily A. Kuhl,et al.  Predictors of quality of life in patients with implantable cardioverter defibrillators. , 2005, Psychosomatics.

[22]  Paul A. Belk,et al.  The Relationship between Pacing Site and Induction or Termination of Sustained Monomorphic Ventricular Tachycardia by Antitachycardia Pacing , 2010, Pacing and clinical electrophysiology : PACE.

[23]  Michael O. Sweeney,et al.  Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-Defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results , 2004, Circulation.

[24]  Wojciech Zareba,et al.  Reduction in inappropriate therapy and mortality through ICD programming. , 2012, The New England journal of medicine.

[25]  A. Boyle,et al.  The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. , 2011, Journal of the American College of Cardiology.

[26]  David L. Hayes,et al.  Cardiac Pacing, Defibrillation and Resynchronization: A Clinical Approach , 2008 .

[27]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[28]  D. Steinhaus,et al.  Internal Defibrillation: Pain Perception of Low Energy Shocks , 2002, Pacing and clinical electrophysiology : PACE.

[29]  W. Bamlet,et al.  Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis: The Detect Supraventricular Tachycardia Study , 2006, Circulation.

[30]  R. Vonthein,et al.  Enhanced Detection Criteria in Implantable Cardioverter Defibrillators: Sensitivity and Specificity of the Stability Algorithm at Different Heart Rates , 2001, Pacing and clinical electrophysiology : PACE.

[31]  C. Morillo,et al.  A prospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease. , 1993, The American journal of cardiology.

[32]  M. Haghjoo,et al.  Efficacy and safety of different antitachycardia pacing sites in the termination of ventricular tachycardia in patients with biventricular implantable cardioverter-defibrillator. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[33]  A. Russo,et al.  The Dilemma of ICD Implant Testing , 2007, Pacing and clinical electrophysiology : PACE.

[34]  G. Boriani,et al.  A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection wind , 2009, European heart journal.

[35]  D. Mark,et al.  Prognostic importance of defibrillator shocks in patients with heart failure. , 2008, The New England journal of medicine.

[36]  M. Brignole,et al.  Clinical evaluation of defibrillation testing in an unselected population of 2,120 consecutive patients undergoing first implantable cardioverter-defibrillator implant. , 2012, Journal of the American College of Cardiology.

[37]  Judy Powell,et al.  Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial: Impact of Therapy and Influence of Adverse Symptoms and Defibrillator Shocks , 2002, Circulation.

[38]  Wojciech Zareba,et al.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.

[39]  C. Stefanadis,et al.  Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[40]  M. Dehghani,et al.  Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator. , 2006, The American journal of cardiology.

[41]  L. Jordaens,et al.  Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. , 2008, International journal of cardiology.

[42]  Dick M. Goedhart,et al.  Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. , 2004, Journal of the American College of Cardiology.

[43]  G. Klein,et al.  Is defibrillation testing required for defibrillator implantation? , 2004, Journal of the American College of Cardiology.

[44]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[45]  S. Kimber,et al.  Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. , 2004, Heart rhythm.

[46]  Jürgen Meyer,et al.  Proarrhythmic Effect of Pacemaker Stimulation in Patients With Implanted Cardioverter-Defibrillators , 2003, Circulation.

[47]  M. Niebauer,et al.  Clinical Investigation of a New Dual‐Chamber Implantable Cardioverter Defibrillator with Improved Rhythm Discrimination Capabilities , 2003, Journal of cardiovascular electrophysiology.

[48]  A. Verma,et al.  Is There an Association Between External Cardioversions and Long-Term Mortality and Morbidity?: Insights From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management Study , 2011, Circulation. Arrhythmia and electrophysiology.

[49]  Jeroen J. Bax,et al.  Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. , 2011, Journal of the American College of Cardiology.

[50]  L. Mitchell,et al.  Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation. , 2002, Journal of the American College of Cardiology.

[51]  C. Wolpert,et al.  Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[52]  A. Moss,et al.  Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator , 2004, Circulation.

[53]  B. Wilkoff,et al.  Optimal Combination of Discriminators for Differentiating Ventricular from Supraventricular Tachycardia by Dual‐Chamber Defibrillators , 2005, Journal of cardiovascular electrophysiology.

[54]  J. Conti,et al.  Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators. , 2006, The American journal of cardiology.

[55]  Y. Okumura,et al.  Intramyocardial Pacing and Sensing for the Enhancement of Cardiac Stimulation and Sensing Specificity , 2007, Pacing and clinical electrophysiology : PACE.

[56]  M. Gold,et al.  Head‐To‐Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study , 2012, Journal of cardiovascular electrophysiology.

[57]  K. Ellenbogen,et al.  Critical Analysis of Dual-Chamber Implantable Cardioverter-Defibrillator Arrhythmia Detection: Results and Technical Considerations , 2001, Circulation.

[58]  G. Breithardt,et al.  RR interval variability in irregular monomorphic ventricular tachycardia and atrial fibrillation. , 1996, Circulation.

[59]  R. Peters,et al.  Clinical Predictors and Efficacy of Antitachycardia Pacing in Patients with Implantable Cardioverter Defibrillators: The Importance of the Patient's Sex , 2001, Pacing and clinical electrophysiology : PACE.

[60]  V. Kühlkamp,et al.  Clinical Experience with the New Detection Algorithms for Atrial Fibrillation of a Defibrillator with Dual Chamber Sensing and Pacing , 1999, Journal of cardiovascular electrophysiology.

[61]  C. Gornick,et al.  Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures. , 2010, Heart rhythm.

[62]  M. Scherillo,et al.  A Randomized Study to Compare Ramp Versus Burst Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: The PITAGORA ICD Trial , 2009, Circulation. Arrhythmia and electrophysiology.

[63]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[64]  J. Alpert,et al.  A theoretically and practically more effective method for interruption of ventricular tachycardia: self-adapting autodecremental overdrive pacing. , 1986, Circulation.

[65]  J. Bourke,et al.  Florid psychopathology in patients receiving shocks from implanted cardioverter-defibrillators , 1997, Heart.

[66]  K. Ellenbogen,et al.  Downloadable Algorithm to Reduce Inappropriate Shocks Caused by Fractures of Implantable Cardioverter-Defibrillator Leads , 2008, Circulation.

[67]  K. Bailey,et al.  Prospective Randomized Trial of Dual Chamber vs. Single Chamber ICDs to Minimize Shocks in Optimally Programmed Devices , 2012 .

[68]  S. Bhavnani,et al.  The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. , 2010, Heart rhythm.

[69]  Wojciech Zareba,et al.  Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. , 2008, Journal of the American College of Cardiology.

[70]  M. Kroll,et al.  Present Understanding of Shock Polarity for Internal Defibrillation: The Obvious and Non‐Obvious Clinical Implications , 2006, Pacing and clinical electrophysiology : PACE.

[71]  Y. Okumura,et al.  Synchronous Ventricular Pacing without Crossing the Tricuspid Valve or Entering the Coronary Sinus—Preliminary Results , 2009, Journal of cardiovascular electrophysiology.

[72]  Walter H Olson,et al.  Discrimination of Ventricular Tachycardia from Supraventricular Tachycardia by a Downloaded Wavelet‐Transform Morphology Algorithm: A Paradigm for Development of Implantable Cardioverter Defibrillator Detection Algorithms , 2002, Journal of cardiovascular electrophysiology.

[73]  M. Santini,et al.  BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial. , 2010, American heart journal.

[74]  P. Friedman,et al.  Advanced ICD troubleshooting: Part I. , 2005, Pacing and clinical electrophysiology : PACE.

[75]  V. Essebag,et al.  Inappropriate Shock Despite Successful Termination of Supraventricular Tachycardia by Antitachycardia Pacing during Charging , 2010, Pacing and clinical electrophysiology : PACE.

[76]  S. Pedersen,et al.  Psychological Intervention Following Implantation of an Implantable Defibrillator: A Review and Future Recommendations , 2007, Pacing and clinical electrophysiology : PACE.

[77]  B. Wilkoff,et al.  Differences in Tachyarrhythmia Detection and Implantable Cardioverter Defibrillator Therapy by Primary or Secondary Prevention Indication in Cardiac Resynchronization Therapy Patients , 2004, Journal of cardiovascular electrophysiology.

[78]  P. Khairy,et al.  Programming ICDs in the Modern Era beyond Out‐of‐the Box Settings , 2011, Pacing and clinical electrophysiology : PACE.

[79]  G. O'hara,et al.  Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging. , 2007, Heart rhythm.

[80]  Zengri J. Wang,et al.  A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. , 2006, Journal of the American College of Cardiology.

[81]  S. Viskin,et al.  Prevention of torsade de pointes in the congenital long QT syndrome: use of a pause prevention pacing algorithm , 1998, Heart.